We’re hiring an experienced Azure Data Engineer to design, build, and scale our next-generation data platform for private lending. You’ll own robust ETL/ELT pipelines using Azure Data Factory, ...

Come Feb. 1, the nearly 42 million low-income Americans on the Supplemental Nutrition Assistance Program, or SNAP, can expect major changes. The United States' largest nutrition assistance program has ...

X is putting its money where its mouth is. The Elon Musk-owned social media platform just pledged it will give $1 million to the user who creates the most popular long-form post using its newly ...

Once exclusively a treatment for diabetes, GLP-1 medications have gone mainstream — forcing restaurants to adjust to changing appetites and nutrition needs. As GLP-1 medications normalize smaller ...

Just when you thought the circular deals couldn’t get any more circular, OpenAI has invested in CEO Sam Altman’s brain computer interface (BCI) startup Merge Labs. Merge Labs, which defines itself as ...

On Thursday, OpenAI announced its investment in neurotech startup Merge Labs, cofounded by its CEO, billionaire Sam Altman. OpenAI will collaborate with the new venture to develop technology to link ...

For women with obesity, GLP-1 medications like Ozempic and Wegovy may help address the metabolic challenges that often intensify during midlife. The hormonal shifts of perimenopause and menopause can ...

The sustainability of weight-loss drugs is under scrutiny as new research shows that people who stop taking glucagon-like peptide-1 (GLP-1) agonists regain the pounds at a steady rate, returning to ...

KSN Skyview video of a wildfire burning north of Hutchinson around 1:30 p.m. Thursday. SpaceX explosion triggers emergencies 'Massive betrayal': Ghislaine Maxwell’s prison treatment sparks outcry ...

(RTTNews) - Clearmind Medicine Inc. (CMND), a clinical-stage biotech company developing psychedelic-derived therapeutics, has announced a reverse share split of its issued and outstanding common ...

GLP-1 usage is on the rise, and researchers are looking for other health benefits associated with the drug, including its effects on bladder health. But as GLP-1s rise in popularity, so do nicknames ...

The World Health Organization (WHO) on Monday issued its first-ever global guidelines on the use of GLP-1 medications for treating obesity as a chronic illness. In a press release, the WHO said this ...